Studies have demonstrated that dysfunction of MIF in AD is due to glycation and oxidation of MIF, which inhibit MIF activity to stimulate glial cells leading to deficiency of clearance of amyloid β (Aβ) protein (Kassaar et al., 2017). This evidence concerns the gene MIF and Alzheimer disease.